CIK 0001946563
- Emerging growth company
60 DEGREES PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- SXTP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 452406880
- Phone
- +1 202-327-5422
- Business address
- 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON, DC, 20036
Securities
- SXTP Common Stock Nasdaq
- SXTPW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | MILLER TYRONE CFO | Grant or award | +11,626 | 26,370 | ||
| 2025-01-02 | MILLER TYRONE CFO | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-05-16 | MILLER TYRONE CFO | Grant or award | +15,000 | $0.22 | $3K | 176,928 |
| 2024-05-16 | MILLER TYRONE CFO | Option exercise · Restricted Stock Units | −15,000 | 0 | ||
| 2024-04-12 | MILLER TYRONE CFO | Grant or award | +60,000 | $0.27 | $16K | 161,928 |
| 2024-04-12 | MILLER TYRONE CFO | Option exercise · Restricted Stock Units | −60,000 | 15,000 | ||
| 2023-11-21 | MILLER TYRONE CFO | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2023-07-12 | MILLER TYRONE Chief Financial Officer | Grant or award · Non-Qualified Stock Options (right to buy) | +240,000 | 240,000 |
Page 1 of 1 · 8 trades